3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Lymphoma, Follicular
5
Lymphoma
4
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma, B-Cell
3
Lymphoma, Large B-Cell, Diffuse
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Diseases
1
Graft vs Host Disease
1
Dendritic Cell Sarcoma, Interdigitating
1
Bronchiolitis Obliterans Syndrome
1
Anemia
1
Interventions
pembrolizumab
2
Paclitaxel
2
Carboplatin
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
sacituzumab govitecan
1
pegfilgrastim
1
atezolizumab
1
Gemcitabine
1
Filgrastim
1
Epirubicin
1
Doxorubicin
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Triple Negative Breast Neoplasms
×
Rituximab
×
Clear all
No trials found.